首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Application of immunoaffinity purification technology as the pretreatment technology for traditional Chinese medicine: Its application to analysis of hesperidin and narirutin in traditional Chinese medicine preparations containing Citri reticulatae Pericarpium
【24h】

Application of immunoaffinity purification technology as the pretreatment technology for traditional Chinese medicine: Its application to analysis of hesperidin and narirutin in traditional Chinese medicine preparations containing Citri reticulatae Pericarpium

机译:免疫亲和纯化技术在中药预处理技术中的应用:在网纹柑皮中药制剂中橙皮苷和那芦丁的分析中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

In the present study, the feasibility of immunoaffinity chromatography (IAC) as a purification technology for the analysis of bioactive components in Traditional Chinese Medicine (TCM) was evaluated. IAC was used to analyze hesperidin (HP) and narirutin (NR) in TCM preparations containing Citri reticulatae Pericarpium (CRP, Chenpi in Chinese). An IAC column for the specific extraction and enrichment of HP and NR from TCM preparations containing CRP was developed and characterized. After HP reacted with carbonyl diimidazole and coupled to protein, it was used to immune mice for the generation of antibody. Through cell fusion, cloning and screening, monoclonal antibody was obtained. The IAC column was constructed by covalently coupling specific monoclonal antibody against HP and NR to CNBr-activated Sepharose 4B and packed into a common solid phase extraction cartridge. The extraction conditions including loading, washing and eluting, as well as flow rate for the extraction of HP and NR were optimized. Under optimal conditions, the maximum capacity, extraction recovery rate and stability of IAC column was also characterized. Results revealed that the maximum capacity of IAC column for HP and NR was approximately 16 mu g and the relative binding capacity per 1 mL of the column volume was 27 mu g. The extraction recovery rate of IAC column for HP and NR at three spiked levels was in the range of 94.05-109.15%. After the repeated application for 5 times, no significant loss of specific recognition was observed. Using high performance liquid chromatography (HPLC) as an effective analytic tool, HP and NR could be successfully separated via IAC column without the inference from impurities, suggesting that the extraction of HP and NR using the prepared IAC column is feasible. The application of IAC can solve the problem of quantitative analysis due to severe interference or low content. Furthermore, pretreatment methods in different matrixes can be unified. The IAC purification procedure can be used as an alternative effective analytical method for the pretreatment of bioactive components in TCM. (C) 2015 Elsevier B.V. All rights reserved.
机译:在本研究中,评估了免疫亲和层析(IAC)作为中药(TCM)中生物活性成分分析的纯化技术的可行性。 IAC被用于分析含有网状柠檬皮(CRP)的中药制剂中的橙皮苷(HP)和纳鲁汀(NR)。开发并表征了一种IAC色谱柱,用于从含有CRP的中药制剂中特异性提取和富集HP和NR。 HP与羰基二咪唑反应并与蛋白质偶联后,可用于免疫小鼠以产生抗体。通过细胞融合,克隆和筛选,获得了单克隆抗体。通过将针对HP和NR的特异性单克隆抗体与CNBr活化的Sepharose 4B共价偶联,构建IAC色谱柱,并将其填充到普通的固相萃取柱中。优化了提取条件,包括上样,洗涤和洗脱以及HP和NR提取的流速。在最佳条件下,还对IAC色谱柱的最大容量,萃取回收率和稳定性进行了表征。结果显示,IAC色谱柱对HP和NR的最大容量约为16μg,每1 mL色谱柱体积的相对结合容量为27μg。在三个加标水平下,IAC色谱柱对HP和NR的萃取回收率在94.05-109.15%的范围内。重复施用5次后,未观察到明显的特异性识别丧失。使用高效液相色谱(HPLC)作为有效的分析工具,可以通过IAC色谱柱成功分离出HP和NR,而没有杂质的推断,这表明使用制备的IAC色谱柱萃取HP和NR是可行的。 IAC的应用可以解决由于干扰严重或含量低而导致的定量分析问题。此外,可以统一不同矩阵中的预处理方法。 IAC纯化程序可用作中药中生物活性成分预处理的替代有效分析方法。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号